BR9306005A - Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao - Google Patents

Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao

Info

Publication number
BR9306005A
BR9306005A BR9306005A BR9306005A BR9306005A BR 9306005 A BR9306005 A BR 9306005A BR 9306005 A BR9306005 A BR 9306005A BR 9306005 A BR9306005 A BR 9306005A BR 9306005 A BR9306005 A BR 9306005A
Authority
BR
Brazil
Prior art keywords
antiprogestin
progestin
estrogen
kit
oral contraception
Prior art date
Application number
BR9306005A
Other languages
English (en)
Inventor
Gary D Hodgen
Krzysztof Chwalisz
Original Assignee
Schering Aktiengesellschaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaf filed Critical Schering Aktiengesellschaf
Publication of BR9306005A publication Critical patent/BR9306005A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BR9306005A 1992-03-02 1993-03-02 Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao BR9306005A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84305892A 1992-03-02 1992-03-02
CN93102182A CN1090481C (zh) 1992-03-02 1993-03-02 雌激素/孕激素/抗孕激素的应用,其组合物和药盒
PCT/US1993/001931 WO1993017686A1 (en) 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Publications (1)

Publication Number Publication Date
BR9306005A true BR9306005A (pt) 1998-06-23

Family

ID=25743002

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9306005A BR9306005A (pt) 1992-03-02 1993-03-02 Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao

Country Status (16)

Country Link
US (1) US7538099B1 (pt)
EP (1) EP0630246B1 (pt)
JP (1) JP4152431B2 (pt)
CN (1) CN1090481C (pt)
AU (1) AU678150B2 (pt)
BR (1) BR9306005A (pt)
CZ (1) CZ291988B6 (pt)
FI (1) FI110307B (pt)
IL (1) IL104915A (pt)
MX (1) MX9301121A (pt)
NO (1) NO311327B1 (pt)
NZ (1) NZ268304A (pt)
PL (2) PL174785B1 (pt)
SK (1) SK285963B6 (pt)
WO (1) WO1993017686A1 (pt)
ZA (1) ZA931492B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
CN1281363A (zh) 1997-11-14 2001-01-24 阿克佐诺贝尔公司 孕激素-抗孕激素体系
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
HUP0201875A3 (en) * 1999-04-29 2003-10-28 Akzo Nobel Nv Use of antiprogestagens for preparing pharmaceutical compositions for contraception in combined therapy
EP1605924B1 (en) 1999-08-31 2008-11-05 Bayer Schering Pharma Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
EP2305230B1 (en) 2001-12-05 2015-11-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
BRPI0412493A (pt) * 2003-07-16 2006-10-17 Duramed Pharmaceuticals Inc métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP2868323A1 (en) 2013-11-03 2015-05-06 Flamina Holding AG A pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
KR20170084086A (ko) 2014-11-17 2017-07-19 아르노 테라퓨틱스 인코포레이티드 오나프리스톤 연장-방출 조성물 및 방법
CN107995864A (zh) * 2015-05-18 2018-05-04 敏捷治疗公司 避孕组合物及提高效能和调节副作用的方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
JP2018528944A (ja) 2015-09-25 2018-10-04 コンテクスト バイオファーマ インコーポレイテッド オナプリストン中間体の製造方法
KR20180113988A (ko) 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US4416822A (en) 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
DE3702383A1 (de) 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5116818A (en) 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5622943A (en) 1992-05-06 1997-04-22 The Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
WO1993021926A1 (en) 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (de) 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption

Also Published As

Publication number Publication date
NO943234L (no) 1994-11-01
MX9301121A (es) 1993-09-01
FI944022A0 (fi) 1994-09-01
AU678150B2 (en) 1997-05-22
PL172790B1 (pl) 1997-11-28
JPH07509218A (ja) 1995-10-12
CZ211194A3 (en) 1995-12-13
NZ268304A (en) 1997-02-24
FI944022A (fi) 1994-09-01
SK104694A3 (en) 1996-01-10
EP0630246B1 (en) 2008-07-16
NO943234D0 (no) 1994-09-01
AU3787993A (en) 1993-10-05
EP0630246A1 (en) 1994-12-28
CZ291988B6 (cs) 2003-07-16
US7538099B1 (en) 2009-05-26
FI110307B (fi) 2002-12-31
PL174785B1 (pl) 1998-09-30
JP4152431B2 (ja) 2008-09-17
SK285963B6 (sk) 2007-12-06
WO1993017686A1 (en) 1993-09-16
ZA931492B (en) 1993-12-23
IL104915A0 (en) 1993-07-08
IL104915A (en) 1998-07-15
NO311327B1 (no) 2001-11-19
CN1090481C (zh) 2002-09-11
EP0630246A4 (en) 2002-07-17
CN1079386A (zh) 1993-12-15

Similar Documents

Publication Publication Date Title
BR9306005A (pt) Método e kit de estrogénio/progestina/antiprogestina para contracepçao oral e regulaçao da menstruaçao
HUP9602982A2 (en) Composition for contraception based on natural eostrogene
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
IL115399A0 (en) A pharmaceutical composition comprising a combination of prostacyclin with an estrogen or progestin
ATE304359T1 (de) Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
HUP9900252A3 (en) Hormonal pharmaceutical combined preparation for contraception and kit
LV11883A (lv) Savienojumi ar antiprogestina un antiestrogena iedarbibu kopejai izmantosanai sievietes kontracepcijai
HUP9904344A3 (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
GB9806364D0 (en) Contraceptive device
HK1129564A1 (zh) 基於促孕劑和雌激素的避孕方法
AU3888697A (en) Progestin/estrogen oral contraceptive
NO971126D0 (no) Eske for kondom
AU4894196A (en) Intrauterine contraceptive device
EP0754701A4 (en) NEW PROGESTERONE COMPOUND AND ITS USE
FI20021041A (fi) Estrogeeni/progestiini/antiprogestiinimenetelmä kuukautisten säätelemiseksi
HU9402354D0 (en) Combined intra-uterine contraceptive device and applicator
GB9615121D0 (en) Metyhod of and means for contraception
GB9401096D0 (en) Method and means for contraception
SI0799043T1 (en) Cyclophasic hormonal regimen containing antiprogestin and progestin
AUPM563194A0 (en) Contraceptive device
AUPM788394A0 (en) Contraceptive device
AUPM997794A0 (en) Contraceptive device
DK0956024T3 (da) Monofasisk oral kontraceptiv fremgangsmåde og kit omfattende en kombination af progestin og östrogen
UA733S (uk) Внутріматковий протизаплідний засіб та пристрій для його введення
GB9402135D0 (en) Compositions for vaginal administratiom

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal